We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byKennedy Langhorn
Modified over 2 years ago
© Crown copyright 2009 Safeguarding public health Vigilance guidance for specific devices Tony Sant/Andy Crosbie – MHRA Presentation to the closed session of the Expert Group on Vigilance for Medical Devices – 15 Nov 2012
© Crown copyright 2009 Background MHRA has for some years issued advice on vigilance reporting for specific types of devices. Guidance is aimed at manufacturers and gives advice on notifying the MHRA of adverse incidents involving specific types of CE-marked medical devices under the medical devices vigilance system. Guidance is intended to facilitate uniform application and implementation of Medical Devices Directive 93/42/EEC. It is supplementary to (and should be read in conjunction with) the latest version of European Commission Guidelines on the Medical Devices Vigilance System - MEDDEV
© Crown copyright 2009 UK device specific vigilance guidance VG 01Joint replacement implants - July 2010 VG 02Artificial heart valves - Nov 2008 VG 03Breast implants - Oct 2009 VG 04Coronary stents - Mar 2009 VG 05IVD blood glucose meters for POCT or home use - Dec 2008 VG 06Inferior vena cava (IVC) filters- Mar 2009 VG 07Intra-ocular lenses- Jun 2009 VG 08Neurostimulators- Dec 2009 VG 09Cardiac Ablation Catheters- July 2010 See: Vigilanceguidanceforspecificdevices/index.htm
© Crown copyright 2009 What do the device specific vigilance guidance documents do? They provide technical / clinical detail to supplement the general guidance on vigilance reporting given in MEDDEV Each MHRA guidance document lists the major recognised types of adverse incident associated with each specific type of medical device and then gives MHRAs opinion on whether it is or is not usually reportable under vigilance as a malfunction or deterioration in the characteristics and/or performance of the device
© Crown copyright 2009 Summary table (see VG 06) of reportable/non- reportable individual adverse incidents under the vigilance system for inferior vena cava filters Summary table (see VG 06) of reportable/non- reportable individual adverse incidents under the vigilance system for inferior vena cava filters Note – for illustrative purposes only, this is not an exhaustive list Reportable Complications during deployment and placement Perforation/erosion Partial or multiple fractures Device migration Progressive tilting/angulation Recurrent/fatal pulmonary embolism Retrieval difficulties Labelling deficiencies MRI induced events Unanticipated events Generally non-reportable Vascular access and device placement related problems Inferior vena cava thrombosis/occlusion Endothelialisation IVC wall penetration Infection Adverse reaction
© Crown copyright 2009 Periodic summary reporting and trend reports MEDDEV includes provision for manufacturers to undertake periodic summary reporting and to submit trend reports to national competent authorities Device specific vigilance guidance can be used to provide guidance on types of adverse incidents which may be suitable for these types of reporting (see for example VG 04 on coronary stents)
© Crown copyright 2009 Why should European device specific vigilance guidance be developed? Device specific vigilance guidance would supplement the general guidance in MEDDEV on a Europe- wide basis Improve co-ordination of advice to industry and prepare for centralised reporting Harmonise use of PSRs and Trend reports in specific areas Minimise effort by concentrating on the lists of incident types to report and not to report and when to use Trend and PSR reports The Commission and Member States are expected to improve co- ordination (Dalli immediate action plan) Now that the MD Regulations have been proposed (Sept 2012) a simple programme of development could begin
© Crown copyright 2009 Next steps Propose Vigilance MDEG discusses and agrees 1 or 2 device specific guidance documents per meeting
© Crown copyright 2009 Safeguarding public health Thanks for listening
Ing. Linda-Jean Worley Consumer and Industrial Goods Directorate Malta Standards Authority MDTA Information Session 27 th October, 2005.
Mike Kreuzer OBE Executive Director, Technical and Regulatory Medical Device Regulation - the next twenty years ?-
1/45 Prepared & Presented by: M.Pharm: Dept. of Pceutics & Pceutical technology L. M. College of Pharmacy STAVAN NAGORI.
RECENT CHANGES IN FEDERAL CHILD WELFARE LEGISLATION Presentation for the State Liaison Officers May 17, 2007 Policy Division, Childrens Bureau Administration.
1 International Clinical Trials: Current Issues in Clinical Trial Regulation and Future Reforms: EU, US, and Beyond: a European perspective International.
Analysing and testing - ETSI initiatives on analysing and testing interoperability in Grids Julian Gallop ETSI Specialist Task Force 331 on ICT Grid Interoperability.
December 2005 EuP Directive : A Framework for setting eco-design requirements for energy-using products European Commission.
Kiev, 04/12/2007 Analysis of EU MRP/DCP procedures regarding to generic applications Dr.Raimonds Lozda, FMS Baltic Ltd.
Reappointment, Tenure and Promotion Workshop June 18, 2013.
Effective treatment. Changing livesBuilding recovery in communities Core Data Set J for Adult Drug & Alcohol Treatment Providers October 2012 Simon Morgan.
Manage an IT Project. Aim This presentation is prepared to support and give a general overview of the ‘How to Manage and IT Project’ Guide and should.
LP Seminar – Madrid – 20 October 2008 EUROPEAN REGIONAL DEVELOPMENT FUND REPORTING & MONITORING PROCEDURES Lead Partner Seminar Madrid, 20 October 2008.
IMPACT Principles and Elements for National Legislation Presented by: Chair, Working Group on Regulatory Implementation, on behalf of Chair, Working Group.
CLU000026EN01-06PP-FP7-Opinion-OR.ppt European Parliament, ITRE, Exchange of views – Industry, Transport, Research & Energy Committee (ITRE)
Ofcom Update on the TV White Space issues Notice: This document has been prepared to assist IEEE It is offered as a basis for discussion and is.
Public Health Local System - HR and Workforce Issues Regional Event Update briefing January 2013 Trade Unions Working in partnership through the Concordat.
R. E. A. CH CONIAC 4 th March, 2008 Tim Harris UK REACH Competent Authority Health and Safety Executive.
2012 SQA Central Training (New Centers) Venue – BISU, Beijing 9, Sept am– 5:00 pm Mary Gao.
1 European Commission, DGENV.D. 3 Strategic Environmental Assessment Directive 2001/42/EC on the assessment of the effects of certain plans and programmes.
Step To Excellence … Getting to Zero Adverse Errors 1.
Presentation title: 32pt Arial Regular, black Recommended maximum length: 1 line Quality is everything! Tricia Ellis AWHILES Conference 2 nd July 2008.
Jayne Sheehan Diane Gilworth January 14, Agenda 11:-00-11:15 Vision and future of Joint Commission Readiness Program- Jayne Sheehan Unscheduled.
16 August 2010© Crown Copyright (2010)1 Module 2.8 Assurance Continuity and Composition.
1 Conclusions reached at IPG-1, 4-8 July 2005 The Intersessional Planning Group held its first meeting at ITU headquarters in Geneva, from 4 to 8 July.
Infrastructure Planning Commission Workshop 2b Working with the IPC: Guidance and issues for promoters.
Performance Reporting Division Texas Education Agency TI ESC Meeting September 18, AYP Update.
Delegation of the European Union to India Peace-building Partnership Regional Call for Proposals – South Asia Information Session for pre-selected Applicants.
Advertising in the EU Alcohol Strategy Dr Jonathan Back Unit 02 – Strategy and Analysis Directorate General for Health and Consumers European Commission.
IHE PATIENT CARE DEVICES DOMAIN The Time for Interoperability is NOW!
1 Guidance document on ex-ante evaluation 15 March 2012 Joint presentation to the ERDF and ESF Evaluation Partnership Meeting.
© 2016 SlidePlayer.com Inc. All rights reserved.